Invesco Ltd. Shattuck Labs, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 18,389 shares of STTK stock, worth $19,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,389

Previous 18,490 0.55%

Holding current value

$19,860

Previous $71,000 9.86%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.0 - $4.85 $303 - $489	-101 Reduced 0.55%	18,389 $64,000
Q2 2024 Aug 13, 2024	BUY	$3.56 - $11.18 $65,824 - $206,718	18,490 New	18,490 $71,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $4.59 $29,916 - $50,857	-11,080 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.22 - $8.89 $742 - $1,564	176 Added 1.61%	11,080 $47,000
Q4 2021 Feb 14, 2022	SELL	$8.36 - $21.08 $6,612 - $16,674	-791 Reduced 6.76%	10,904 $93,000
Q3 2021 Nov 15, 2021	BUY	$17.57 - $28.95 $42,941 - $70,753	2,444 Added 26.42%	11,695 $239,000
Q2 2021 Aug 17, 2021	BUY	$24.14 - $37.68 $223,319 - $348,577	9,251 New	9,251 $268,000

Others Institutions Holding STTK

# of Institutions

Shares Held

28.8M

Call Options Held

300

Put Options Held

1.2K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $45.8M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account